A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma

Journal of Gastrointestinal Oncology, 04/09/2012

Although capecitabine and lapatinib is well tolerated, it is not an effective regimen in patients with refractory colorectal adenocarcinoma.

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List